SBI Life – Positive

IRDAI Sets Up Two Expert Panels to Draft IndAS-Aligned Risk-Based Capital

Positive for SBI Life
Analysts say SBI Life has 51% ULIP linked policies

BFSI, Capital Market Theme Stocks Rise

Banks Seeings FII Flows
NBFCs Buzzing On IIFL Finance Team
Brokerages Bullish On Capital Market/ Wealth Management
Expect Record October SIP Numbers-Today

MOSL-AARTI INDUSTRIES

INITIATING COVERAGE: Fuel additives lead; core chemistry gains momentum

(ARTO IN, Mkt Cap: USD 1.8b, CMP: ₹459 | TP: ₹600 | Upside: 31% | Rating: BUY)

NIFTY EXTENDS GAINS, ABOVE 25400 MARK

INDIA - U.S TRADE DEAL UPDATE

U.S Officials Team Visited India On November 2-3 For Talks On Proposed BTА

Both Sides Remain Engaged For Early Conclusion Of First Tranche

Both Sides Discussed Technical Issues Pertaining To Customs

Both Sides Discussed Trade Facilitation, Removing Non-tariff Barriers

NILESH SHAH, KOTAK MAHINDRA AMC

Market Underperformed In The Last 2 Years, Valuations Have Become 30% Cheaper

I Was In The US Before Diwali, Saw Flls Willing To Cut Cheque For India

Lower Crude Oil Prices Have Been A Catalyst

FIls With On Ground Presence Look At Mid & Small Ca

Positive for Navin fluorine

USFDA clear Asundixian for marketing in USA.

Asundixian is a secondary stroke inhibitor.

This would be Navin’s second molecule with Bayer.

As per secondary research, size of this molecule is approx USD 3bn euros. Almost at par to Nubeqas current sales.

Brokerage Note

NIRMAL JAIN, IIFL FINANCE

Growth Has Been Strong And We Needed Capital

Strong Balance Sheet Will Enable Co-Lending By Banks

The Funds Will Almost Double Our Capital Adequacy

Expect 70% Funds For New Loans, 30% To Repay Borrowings

The Funds Will Sustain Growth For Next 3-4 Years

GE SHIPPING COMPANY, G. SHIVAKUMAR

War Tensions & Inefficiencies Have Reduced Lately

Crude Tanker Rates Have Fallen From Highs By Approx 50% Over The Past 10 Days

Freight Rates Across The Board Are Higher YoY, But Are Off Highs In Q2

Asset Prices Went Ballistic, Especially Crude Tankers, Over Past 4 Months

We Are Modernising Our Fleet, Continue To Maintain Over ₹8,000 Cr In Cash

IIFL Finance in focus on Blackstone investment

Nirmal Jain, Founder & MD, IIFL Finance says

-Fund raise doubles Capital Adequacy

- Blackstone will get 1/2 board seats

- Cost of funds will dip with rating revision

-Net Profit can move to ₹5000cr by FY29

HSBC says

If Fils Come In, Their Focus Will Be On Largecaps

Large Caps Have A Very Reasonable Valuation

Radico Khaitan Ltd – RAMPUR INDIAN SINGLE MALT BRAND POSITIONING

Rampur Indian Single Malt unveils new brand positioning '43° | 2° – Born in Nature’s Frequency':

- New positioning based on Himalayan temperature extremes of 43°C in summer and 2°C in winter

- Rampur Distillery selected to represent Asia in 'The 8 Continent Series' international scientific study

- Nine Rampur expressions featured in Jim Murray’s WhiskyBible 2026 with an average score of 91.9 points

- First Indian single malt presented across four major UK airports: Heathrow, Gatwick, Manchester, and Birmingham

- Prestige & Above segment recorded 35.8% volume growth in Q1 FY2027 reaching 5.28 million cases

- Company aims to grow luxury and semi-luxury portfolio by approximately 25% in FY2027

REDINGTON, V. S. HARIHARAN

SSG Business To Drive Double-Digit Growth Over Next 3-5 Years

Strong Growth Expected In Al Infra, Given India's Gap With Western Markets

Enterprise Segment Growing At 30-35%, Excluding Data Centre Business

Data Center Hardware Is A Lower Margin Business

CEIGALL INDIA – MANAGEMENT UPDATE

• FY27 order inflows expected to exceed ₹6,000 Cr; already achieved ₹5,300 Cr in H1.

• FY27 revenue growth guidance of at least 15%.

• Targeting ₹540 Cr debt reduction in FY27.

• Expected to receive ₹250 Cr from the sale of 3 assets during FY27.

BATA INDIA: CO. SAYS NEW PRODUCT LINES TO DRIVE GROWTH, REITERATES TARGET TO DOUBLE TURNOVER BY 2030

BANARI AMMAN SUGAR – Q2 FY27 (STANDALONE)

• Net Profit: ₹30.95 Cr | YoY ↓ 27.52% | QoQ: Profit vs Loss

• Revenue: ₹340.22 Cr | YoY ↓ 40.49% | QoQ ↑ 97.28%

• EBITDA: ₹45.41 Cr | YoY ↓ 39.39% | QoQ: Profit vs Loss

• EBITDA Margin: 13.35% vs 13.11% (YoY), -3.00% (QoQ)

AUROBINDO PHARMA

Arm Apitoria Pharma Receives Establishment Inspection Report From US FDA

Establishment Inspection Report Classifies Facility As Voluntary Action Indicated

US FDA inspected Telangana-based Unit-II, an API mfg facility of arm from Sept 7-15, 2026

OCTOBER MF DATA

Net Equity Inflow At 32,994 Cr Vs ₹38,293.5 Cr Inflow (MoM)

Total AUM At ₹83.39 Lk Cr Vs (MoM) 82.64 Lk Cr

INDIA FINANCE, COMMERCE MINISTRIES HOLDING TALKS TO RESOLVE THE MATTER-GOVERNMENT - RTRS

BAJAJ FINANCE: BAJAJ FINANCE: CO IS SET TO LAUNCH A SHARE SALE TO RAISE AS MUCH AS 117 BILLION RUPEES FROM INSTITUTIONAL INVESTORS AS SOON AS THIS WEEK

EMPIND: Q2 STANDALONE NET PROFIT 176.9M RUPEES VS 123.9M (YOY)

EMPIND: Q2 EBITDA 296.8M RUPEES VS 211.4M (YOY); Q2 EBITDA MARGIN 15.32% VS 11.72% (YOY)

EMPIND: Q2 REVENUE 1.94B RUPEES VS 1.8B (YOY)